Current Firm
OrbiMed Advisors
Investments
1+ companies
Focus
Biotech, Digital Health
Sven H. Borho is a founding partner at OrbiMed who heads the firm's public equity team and serves as portfolio manager for flagship listed healthcare strategies, including the London-listed Worldwide Healthcare Trust, giving him an unusual role that spans both specialist healthcare investing and public trust management. He emphasizes a science-first investment philosophy where understanding underlying biology and clinical science takes priority over financial metrics, distinguishing his approach from more traditional public equity managers.
Sven H. Borho is a Managing Partner, OrbiMed Advisors at OrbiMed Advisors, based in New York, NY.
Sven's investment focus spans Biotech, Digital Health, AI, primarily investing at the Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments include Carl L. Gordon. These investments span Biotech and Digital Health.
Sven H. Borho is a Managing Partner, OrbiMed Advisors at OrbiMed Advisors, based in New York, NY. Their investment focus includes Biotech, Digital Health, AI.
Sven H. Borho focuses on investments in Biotech, Digital Health, AI through OrbiMed Advisors. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Sven H. Borho's notable portfolio investments include Carl L. Gordon. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Sven H. Borho is currently at OrbiMed Advisors, headquartered in New York, NY, serving as Managing Partner, OrbiMed Advisors.